Clinical Trials in Salt Lake City

Showing 8481-8500 of 12,670 trials

INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP

NCT03547297

This study will use specific diagnostic tests on a group of patients who are experiencing symptoms typical of acute hepatic porphyria (AHP) to determine how many have the condition, and to potentially help improve the diagnostic process for patients in the future.

Acute Hepatic PorphyriaHepatic PorphyriasAcute Intermittent Porphyria (AIP)+4 more

Alnylam Pharmaceuticals212 participantsStarted May 2018

Pasadena, California, United States • Jacksonville, Florida, United States • Margate, Florida, United States +9 more locations

TERMINATEDPhase 2< 1 mile

Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib

NCT02226172

A lead-in cohort of \~20 patients with primary or secondary myelofibrosis previously treated with 1 or more Janus kinase inhibitors enrolled to single-agent glasdegib to evaluate safety and tolerability. Following the lead-in, a phase 2, double blind, 2-arm study, randomized 2:1 to oral single-agent glasdegib versus placebo in 201 patients resistant or intolerant to ruxolitinib.

Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis

Pfizer21 participantsStarted Oct 2014

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +16 more locations

INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP

Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib

Find Trials by Condition in Salt Lake City

Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation.

Detection of Cytomegalovirus Virus in Neonates

Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII

Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma

A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)

Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer

A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis

Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma

Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery

Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome

Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)

Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD

Early Family-Centered Prevention of Drug Use Risk (Aka Early Steps)

Pragmatic Airway Resuscitation Trial

PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB